Search Results
Search for other papers by U Leonhardt in
Google Scholar
PubMed
Search for other papers by E Gerdes in
Google Scholar
PubMed
Search for other papers by U Ritzel in
Google Scholar
PubMed
Search for other papers by G Schafer in
Google Scholar
PubMed
Search for other papers by W Becker in
Google Scholar
PubMed
Search for other papers by G Ramadori in
Google Scholar
PubMed
In this study, plasma leptin concentrations were measured in rats artificially rendered hyper- or hypothyroid by administration of thyroxine or TRH, by administration of methimazole, or by thyroidectomy. Compared with those in untreated controls, leptin immunoreactivity was not affected in the hyperthyroid state, but was significantly increased in hypothyroid animals. Methimazole administration for longer time periods caused a stepwise increase in plasma leptin immunoreactivity. Greatest leptin concentrations were seen after 28 days of methimazole. Seven days after withdrawal of the methimazole, leptin concentrations no longer differed from those observed in control animals. In hypothyroid animals, expression of leptin mRNA was increased in both retroperitoneal and epididymal adipose tissue, whereas no difference was seen for subcutaneous or mesenteric fat. Incubation of rat leptin with plasma of eu- or hypothyroid rats and subsequent HPLC analysis of leptin plasma peaks gave no indication of an altered hormone stability. We conclude that, in hypothyroid rats, leptin concentrations may be increased as a result of stimulated leptin synthesis in retroperitoneal and epididymal adipose tissue.
Search for other papers by FW Wassen in
Google Scholar
PubMed
Search for other papers by EP Moerings in
Google Scholar
PubMed
Search for other papers by H van Toor in
Google Scholar
PubMed
Search for other papers by G Hennemann in
Google Scholar
PubMed
Search for other papers by ME Everts in
Google Scholar
PubMed
Transport of thyroxine (T(4)) into the liver is inhibited in fasting and by bilirubin, a compound often accumulating in the serum of critically ill patients. We tested the effects of chronic and acute energy deprivation, bilirubin and its precursor biliverdin on the 15-min uptake of [(125)I]tri-iodothyronine ([(125)I]T(3)) and [(125)I]T(4) and on TSH release in rat anterior pituitary cells maintained in primary culture for 3 days. When cells were cultured and incubated in medium without glucose and glutamine to induce chronic energy deprivation, the ATP content was reduced by 45% (P<0. 05) and [(125)I]T(3) uptake by 13% (NS), but TSH release was unaltered. Preincubation (30 min) and incubation (15 min) with 10 microM oligomycin reduced ATP content by 51% (P<0.05) and 53% (P<0. 05) under energy-rich and energy-poor culture conditions respectively; [(125)I]T(3) uptake was reduced by 66% (P<0.05) and 64% (P<0.05). Neither bilirubin nor biliverdin (both 1-200 microM) affected uptake of [(125)I]T(3) or [(125)I]T(4). Bilirubin (1-50 microM) did not alter basal or TRH-induced TSH release. In conclusion, the absence of inhibitory effects of chronic energy deprivation and bilirubin on thyroid hormone uptake by pituitary cells supports the view that the transport is regulated differently than that in the liver.
Search for other papers by Edwin J W Geven in
Google Scholar
PubMed
Search for other papers by Gert Flik in
Google Scholar
PubMed
Search for other papers by Peter H M Klaren in
Google Scholar
PubMed
) axis where hypothalamic TRH stimulates the release of pituitary TSH, which stimulates the release of THs. Similarly, the hypothalamic–pituitary–interrenal (HPI) axis controls the release of cortisol from the interrenal cells in the head kidney, via
Search for other papers by PJ O'Shea in
Google Scholar
PubMed
Search for other papers by GR Williams in
Google Scholar
PubMed
Thyroid hormones exert a range of developmental and physiological actions in all vertebrates. Serum concentrations of L-thyroxine (T4) and 3,5,3 -L-triiodothyronine (T3) are maintained by a negative feedback loop involving T3-inhibition of hypothalamic thyrotrophin releasing hormone (TRH) and pituitary thyroid stimulating hormone (TSH) secretion, and by tissue specific and hormone-regulated expression of the three iodothyronine deiodinase enzymes that activate or metabolise thyroid hormones. T3 actions are mediated by two T3-receptors, TRalpha and TRbeta, which act as hormone-inducible transcription factors. The TRalpha (NR1A1) and TRbeta (NR1A2) genes encode mRNAs that are alternatively spliced to generate 9 mRNA isoforms (TRalpha1, alpha2, alpha3, Deltaalpha1, Deltaalpha2, beta1, beta2, beta3 and Deltabeta3), of which four (TRalpha1, alpha2, beta1 and beta2) are known to be expressed at the protein level in vivo. The numerous TR mRNAs are expressed widely in tissue- and developmental stage-specific patterns, although it is important to note that levels of mRNA expression may not correlate with receptor protein concentrations in individual tissues. The TRalpha2, alpha3, Deltaalpha1 and Deltaalpha2 transcripts encode proteins that fail to bind T3 in vitro. These non-binding isoforms, in addition to TRDeltabeta3 which does bind hormone, may act as dominant negative antagonists of the true T3-binding receptors in vitro, but their physiological functions and those of the TRbeta3 isoform have not been determined. In order to obtain a new understanding of the complexities of T3 action in vivo and the role of TRs during development, many mouse models of disrupted or augmented thyroid hormone signalling have been generated. The aim of this review is to provide a picture of the physiological actions of thyroid hormones by considering the phenotypes of these genetically modified mice.
Search for other papers by Maria H Warner in
Google Scholar
PubMed
Search for other papers by Geoffrey J Beckett in
Google Scholar
PubMed
pituitary T 3 levels in illness, which under normal circumstances should lead to an increase in thyrotropin-releasing hormone (TRH) and TSH secretion. It seems that the low TSH associated with critical illness (or failure of TSH to rise in the presence of a
Search for other papers by K J Oliveira in
Google Scholar
PubMed
Search for other papers by G S M Paula in
Google Scholar
PubMed
Search for other papers by R H Costa-e-Sousa in
Google Scholar
PubMed
Search for other papers by L L Souza in
Google Scholar
PubMed
Search for other papers by D C Moraes in
Google Scholar
PubMed
Search for other papers by F H Curty in
Google Scholar
PubMed
Search for other papers by C C Pazos-Moura in
Google Scholar
PubMed
. 2002 , Challisa et al. 2003 ). In addition, NPY originating in the hypothalamic arcuate nucleus exerts a profound inhibitory effect on the thyroid axis via effects on hypophysiotropic thyrotropin-releasing hormone (TRH) neurons. Chronic
Search for other papers by Nadia Schoenmakers in
Google Scholar
PubMed
Search for other papers by Kyriaki S Alatzoglou in
Google Scholar
PubMed
Search for other papers by V Krishna Chatterjee in
Google Scholar
PubMed
Search for other papers by Mehul T Dattani in
Google Scholar
PubMed
the neuropeptides TRH, thyrotropin-releasing hormone; GHRH, growth-hormone releasing hormone; SST, somatostatin; CRH, corticotropin-releasing hormone ( Shimogori et al . 2010 , Diaz et al . 2015 ). In the developing rat, hypothalamus Trh cells first
Department of Pediatrics, Department of Medicine, Department of Pediatric Endocrinology, Endocrinology and Metabolism, Developmental Biology and Cancer Programme, Department of Pharmacology and Therapeutics, Center for Reproductive Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Sjoerd D Joustra in
Google Scholar
PubMed
Search for other papers by Onno C Meijer in
Google Scholar
PubMed
Department of Pediatrics, Department of Medicine, Department of Pediatric Endocrinology, Endocrinology and Metabolism, Developmental Biology and Cancer Programme, Department of Pharmacology and Therapeutics, Center for Reproductive Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Charlotte A Heinen in
Google Scholar
PubMed
Search for other papers by Isabel M Mol in
Google Scholar
PubMed
Search for other papers by El Houari Laghmani in
Google Scholar
PubMed
Search for other papers by Rozemarijn M A Sengers in
Google Scholar
PubMed
Search for other papers by Gabriela Carreno in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Nienke R Biermasz in
Google Scholar
PubMed
Search for other papers by Daniel J Bernard in
Google Scholar
PubMed
Search for other papers by Jan M Wit in
Google Scholar
PubMed
Search for other papers by Wilma Oostdijk in
Google Scholar
PubMed
Search for other papers by Ans M M van Pelt in
Google Scholar
PubMed
Search for other papers by Geert Hamer in
Google Scholar
PubMed
Search for other papers by Gerry T M Wagenaar in
Google Scholar
PubMed
-producing cells, catalog# VC6-15462), Somatostatin (catalog# VC6-15126), Gnrh1 (catalog# VC6-15463), Ghrh (catalog# VC6-15466), Crh (catalog# VC6-15465), Trh (catalog# VC6-15464), Glutamic acid decarboxylase 67 (Gad67, GABAergic cells, catalog# VC6
Search for other papers by LA Nolan in
Google Scholar
PubMed
Search for other papers by CK Thomas in
Google Scholar
PubMed
Search for other papers by A Levy in
Google Scholar
PubMed
The anterior pituitary is active mitotically and apoptotically under basal conditions and in response to a variety of physiological and pathophysiological stimuli. Hypothyroidism in man is associated with a modest but very occasionally dramatic increase in overall pituitary size. The mechanisms underlying this reversible phenomenon remain obscure. In the present study we have examined young adult rat anterior pituitary following surgical thyroidectomy and subsequent thyroid hormone treatment and withdrawal using an extremely accurate system for quantifying directly identified mitotic and apoptotic events. Despite the expected increase in the number and/or proportion of immunohistochemically identifiable thyrotrophs three weeks after thyroidectomy, mitotic and apoptotic activity remained unchanged, as did pituitary wet weight, in comparison with sham-operated and intact controls. In contrast, mitotic but not apoptotic activity was enhanced by treatment of thyroidectomized animals with thyroid hormones (triiodothyronine (T3) and thyroxine (T4) 1.8 microg and 3.6 microg/100 g body weight per day respectively), and once again declined to levels seen in intact animals within 72 h of subsequent thyroid hormone withdrawal. Thyroid hormone-induced enhancement of mitotic activity was also seen in intact rats treated with similar doses of thyroid hormones for 7 days and in thyroidectomized rats treated for a similar period with very low dose thyroid hormone replacement at a level that had no effect on raised hypothalamic TRH- or pituitary TSHbeta-transcript prevalence (0.018 microg T3 plus 0.036 microg T4/100 g body weight per day). Thus changes in mitotic and apoptotic activity are unlikely to be the principle mechanism for the apparent increase in thyrotrophs up to 4 weeks after thyroidectomy. In contrast, the data indicate that thyroid hormones have a permissive effect on anterior pituitary mitotic activity in thyroidectomized male rats. Thyroid hormone-induced enhancement of mitotic activity in intact rats further suggests that in euthyroid rats, ambient thyroid hormone levels are a limiting factor for anterior pituitary mitotic activity. In summary, this time course study of young, male rats has shown for the first time that thyroidectomy, thyroid hormone replacement and subsequent withdrawal has no significant effect on anterior pituitary apoptotic activity. Secondly, it has shown that the anterior pituitary mitotic response to thyroidectomy is blocked by complete thyroid hormone deprivation, but can be restored by very low level thyroid hormone replacement, and thirdly that in intact animals thyroid hormone levels significantly limit anterior pituitary mitotic activity.
Search for other papers by Camila Calvino in
Google Scholar
PubMed
Search for other papers by Luana L Souza in
Google Scholar
PubMed
Search for other papers by Ricardo H Costa-e-Sousa in
Google Scholar
PubMed
Search for other papers by Norma A S Almeida in
Google Scholar
PubMed
Search for other papers by Isis H Trevenzoli in
Google Scholar
PubMed
Search for other papers by Carmen C Pazos-Moura in
Google Scholar
PubMed
al . 1997 , Ahima & Flier 2000 , Seoane et al . 2000 , Ortiga-Carvalho et al . 2002 , Cabanelas et al . 2006 , Araujo et al . 2009 ). Leptin has been shown to stimulate the hypothalamic production of TRH ( Legradi et al . 1997 , Friedman
